135
Views
0
CrossRef citations to date
0
Altmetric
Methodology

Improving access to shared decision-making for Hispanics/Latinos with inadequately controlled type 2 diabetes mellitus

, , , , &
Pages 619-625 | Published online: 30 Apr 2015
 

Abstract

Purpose

To describe the cultural and linguistic adaptation and Spanish translation of an English-language patient decision aid (PDA) for use in supporting shared decision-making in Hispanics/Latinos with type 2 diabetes mellitus (T2DM), a group at a high risk for complications.

Patients and methods

A steering committee of endocrinologists, a primary care physician, a certified diabetes educator, and a dietician, each with extensive experience in providing care to Hispanics/Latinos was convened to assess a PDA developed for English-speaking patients with T2DM. English content was reviewed for cultural sensitivity and appropriateness for a Hispanic/Latino population. A consensus-building process and iterative version edits incorporated clinician perspectives. The content was adapted to be consistent with traditional Hispanic/Latino cultural communication precepts (eg, avoidance of hostile confrontation; value for warm interaction; respect for authority; value of family support for decisions). The PDA was translated by native-speaking individuals with diabetes expertise.

Results

The PDA underwent testing during cognitive interviews with ten Spanish-speaking Hispanics/Latinos with T2DM to ensure that the content is reflective of the experience, understanding, and language Hispanic/Latino patients use to describe diabetes and treatment. Content edits were made to assure a literacy level appropriate to the audience, and the PDA was produced for online video dissemination.

Conclusion

High-quality, well-developed tools to facilitate shared decision-making in populations with limited access to culturally sensitive information can narrow gaps and align care with individual patient preferences. A newly developed PDA is available for shared decision-making that provides culturally appropriate treatment information for inadequately controlled Hispanics/Latinos with T2DM. The impact on the overall health of patients and care management of T2DM requires further study.

Acknowledgments

The authors wish to acknowledge Anne Farley, RN MSM, for her assistance in the adaptation process. This research and report were developed with funding from Janssen Scientific Affairs, LLC.

Disclosure

RAB is an employee of Janssen Scientific Affairs, LLC and a Stockholder in Johnson and Johnson. The authors report no other conflicts of interest in this work.